Literature DB >> 17350837

Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitors.

Brian L Hodous1, Stephanie D Geuns-Meyer, Paul E Hughes, Brian K Albrecht, Steve Bellon, Sean Caenepeel, Victor J Cee, Stuart C Chaffee, Maurice Emery, Jenne Fretland, Paul Gallant, Yan Gu, Rebecca E Johnson, Joseph L Kim, Alexander M Long, Michael Morrison, Philip R Olivieri, Vinod F Patel, Anthony Polverino, Paul Rose, Ling Wang, Huilin Zhao.   

Abstract

A novel class of selective Tie-2 inhibitors was derived from a multi-kinase inhibitor 1. By reversing the amide connectivity and incorporating aminotriazine or aminopyridine hinge-binding moieties, excellent Tie-2 potency and KDR selectivity could be achieved with 3-substituted terminal aryl rings. X-ray co-crystal structure analysis aided inhibitor design. This series was evaluated on the basis of potency, selectivity, and rat pharmacokinetic parameters.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350837     DOI: 10.1016/j.bmcl.2007.02.067

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Type-II kinase inhibitor docking, screening, and profiling using modified structures of active kinase states.

Authors:  Irina Kufareva; Ruben Abagyan
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

2.  The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors.

Authors:  Allison S Harney; George S Karagiannis; Jeanine Pignatelli; Bryan D Smith; Ece Kadioglu; Scott C Wise; Molly M Hood; Michael D Kaufman; Cynthia B Leary; Wei-Ping Lu; Gada Al-Ani; Xiaoming Chen; David Entenberg; Maja H Oktay; Yarong Wang; Lawrence Chun; Michele De Palma; Joan G Jones; Daniel L Flynn; John S Condeelis
Journal:  Mol Cancer Ther       Date:  2017-08-24       Impact factor: 6.261

3.  Sequence determinants of a specific inactive protein kinase conformation.

Authors:  Sanjay B Hari; Ethan A Merritt; Dustin J Maly
Journal:  Chem Biol       Date:  2013-06-20

4.  Tumor angiogenesis: insights and innovations.

Authors:  Fernando Nussenbaum; Ira M Herman
Journal:  J Oncol       Date:  2010-04-26       Impact factor: 4.375

5.  Identification of Cryptic Binding Sites Using MixMD with Standard and Accelerated Molecular Dynamics.

Authors:  Richard D Smith; Heather A Carlson
Journal:  J Chem Inf Model       Date:  2021-02-18       Impact factor: 4.956

6.  In Silico Exploration for Novel Type-I Inhibitors of Tie-2/TEK: The Performance of Different Selection Strategy in Selecting Virtual Screening Candidates.

Authors:  Peichen Pan; Huiyong Sun; Hui Liu; Dan Li; Wenfang Zhou; Xiaotian Kong; Youyong Li; Huidong Yu; Tingjun Hou
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

Review 7.  Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?

Authors:  Zheng Zhao; Hong Wu; Li Wang; Yi Liu; Stefan Knapp; Qingsong Liu; Nathanael S Gray
Journal:  ACS Chem Biol       Date:  2014-04-29       Impact factor: 5.100

8.  N+-C-H···O Hydrogen bonds in protein-ligand complexes.

Authors:  Yukihiro Itoh; Yusuke Nakashima; Shuichiro Tsukamoto; Takashi Kurohara; Miki Suzuki; Yoshitake Sakae; Masayuki Oda; Yuko Okamoto; Takayoshi Suzuki
Journal:  Sci Rep       Date:  2019-01-25       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.